Premarket Mover: Protalix Biotherapeutics Inc (PLX) Up 3.39%

Wednesday, August 10, 2022 07:10 AM | InvestorsObserver Analysts

Mentioned in this article

Protalix Biotherapeutics Inc (PLX) has risen Wednesday morning, with the stock climbing 3.39% in pre-market trading to 1.22. PLX's short-term technical score of 32 indicates that the stock has traded less bullishly over the last month than 68% of stocks on the market. In the Biotechnology industry, which ranks 117 out of 146 industries, the stock ranks higher than 43% of stocks. Protalix Biotherapeutics Inc has risen 6.31% over the past month, closing at $1.09 on July 13. During this period of time, the stock fell as low as $1.05 and as high as $1.14. The company has an average price target of $11.00.

PLX has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on PLX!
Protalix Biotherapeutics Inc has a Long-Term Technical rank of 73. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 27% of the market scoring higher. In the Biotechnology industry which is number 75 by this metric, PLX ranks better than 75% of stocks.

Important Dates for Investors in PLX:

-Protalix Biotherapeutics Inc is set to release earnings on 8/15/2022. Over the last 12 months, the company has reported EPS of $-0.53. -We do not have a set dividend date for Protalix Biotherapeutics Inc at this time. Click Here To Get The Full Report on Protalix Biotherapeutics Inc (PLX)

Share this article: